Cantor Fitzgerald restated their overweight rating on shares of Celldex Therapeutics (NASDAQ:CLDX – Free Report) in a ...

(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Cantor Fitzgerald CEO Howard Lutnick is co-chair of the transition team for Donald Trump. The SEC says his firm caused two ...

WASHINGTON (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75-million penalty to settle Securities ...

Cantor Fitzgerald has recently initiated ARS Pharmaceuticals Inc (SPRY) stock to Overweight rating, as announced on August 20, 2024, according to Finviz. Earlier, on August 13, 2024, Raymond James had ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $14.99 which represents a slight increase of $0.22 or 1.49% from the prior close of $14.77. The stock opened at $14.9 ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

The global financial services firm paid $6.75 million to settle the charges brought by the Securities and Exchange Commission.

On that date, Aquila announced separate agreements with New York Life and Cantor Fitzgerald to sell its investment advisory business. Pending the expected completion of those transactions in July ...